ARAH Stock Overview
Aleafia Health Inc., together with its subsidiaries, operates as cannabis health and wellness company in Canada, Europe, and Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Aleafia Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.015 |
| 52 Week High | CA$0.079 |
| 52 Week Low | CA$0.0005 |
| Beta | 1.73 |
| 11 Month Change | 0% |
| 3 Month Change | 3,000.00% |
| 1 Year Change | -50.79% |
| 33 Year Change | -94.60% |
| 5 Year Change | -97.67% |
| Change since IPO | -96.70% |
Recent News & Updates
Recent updates
Shareholder Returns
| ARAH | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 1.1% |
| 1Y | -50.8% | -19.0% | 7.2% |
Return vs Industry: ARAH underperformed the German Pharmaceuticals industry which returned -28.2% over the past year.
Return vs Market: ARAH underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| ARAH volatility | |
|---|---|
| ARAH Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: ARAH's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ARAH's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 158 | Tricia Symmes | www.aleafiahealth.com |
Aleafia Health Inc., together with its subsidiaries, operates as cannabis health and wellness company in Canada, Europe, and Australia. The company owns and operates a virtual network of medical cannabis clinics staffed through physicians and nurse practitioners. Its product portfolio includes cannabis oils, capsules, edibles, cannabis-infused sublingual strips, pre-roll, milled, and vape cartridges; bath bombs and soft gels; hang dried, hand trimmed, long cured, and small batch dried flower; and concentrates.
Aleafia Health Inc. Fundamentals Summary
| ARAH fundamental statistics | |
|---|---|
| Market cap | €5.48m |
| Earnings (TTM) | -€23.53m |
| Revenue (TTM) | €29.13m |
0.2x
P/S Ratio-0.2x
P/E RatioIs ARAH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARAH income statement (TTM) | |
|---|---|
| Revenue | CA$42.85m |
| Cost of Revenue | CA$36.85m |
| Gross Profit | CA$6.00m |
| Other Expenses | CA$40.61m |
| Earnings | -CA$34.61m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.086 |
| Gross Margin | 14.00% |
| Net Profit Margin | -80.77% |
| Debt/Equity Ratio | -499.1% |
How did ARAH perform over the long term?
See historical performance and comparison